We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1026
DELISTED
Akero Therapeutics
AKRO
| $440K | ﹤0.01% |
9,423
+2,078
| +28% | +$95.2K |
|
1027
Texas Roadhouse
TXRH
$12.7B
| $440K | ﹤0.01% |
3,915
-7,959
| -67% | -$875K |
|
1028
LGI Homes
LGIH
$1.4B
| $438K | ﹤0.01% |
3,250
+276
| +9% | +$33.1K |
|
1029
Acadia Healthcare
ACHC
$3.17B
| $438K | ﹤0.01% |
5,501
-158
| -3% | -$11.4K |
|
1030
Enpro
NPO
$7.05B
| $437K | ﹤0.01% |
3,272
+254
| +8% | +$27K |
|
1031
East-West Bancorp
EWBC
$17.9B
| $436K | ﹤0.01% |
8,264
-120
| -1% | -$6.09K |
|
1032
Jones Lang LaSalle
JLL
$15.1B
| $435K | ﹤0.01% |
2,791
-33
| -1% | -$4.68K |
|
1033
BridgeBio Pharma
BBIO
$16.5B
| $435K | ﹤0.01% |
25,280
+2,324
| +10% | +$35K |
|
1034
Evolent Health
EVH
$475M
| $434K | ﹤0.01% |
14,329
+4,680
| +49% | +$151K |
|
1035
NETSCOUT
NTCT
$2.86B
| $434K | ﹤0.01% |
14,022
+1,885
| +16% | +$55.4K |
|
1036
Infosys
INFY
$45B
| $433K | ﹤0.01% |
26,924
+4,866
| +22% | +$76.1K |
|
1037
Graphic Packaging
GPK
$3.26B
| $431K | ﹤0.01% |
+17,942
| New | +$450K |
|
1038
Verra Mobility
VRRM
$615M
| $430K | ﹤0.01% |
21,821
+1,515
| +7% | +$26.8K |
|
1039
RXO
RXO
$4.23B
| $429K | ﹤0.01% |
+18,917
| New | +$381K |
|
|
MDC
1040
DELISTED
M.D.C. Holdings, Inc.
MDC
| $429K | ﹤0.01% |
9,168
+717
| +8% | +$29.9K |
|
1041
Repligen
RGEN
$7.44B
| $428K | ﹤0.01% |
3,025
-47
| -2% | -$7.54K |
|
1042
Cathay General Bancorp
CATY
$4.2B
| $428K | ﹤0.01% |
13,287
+746
| +6% | +$23.7K |
|
|
FRG
1043
DELISTED
Franchise Group, Inc.
FRG
| $424K | ﹤0.01% |
+14,808
| New | +$424K |
|
1044
Apple Hospitality REIT
APLE
$3.96B
| $424K | ﹤0.01% |
28,066
+2,740
| +11% | +$41.5K |
|
1045
Schrodinger
SDGR
$1.12B
| $424K | ﹤0.01% |
+8,488
| New | +$287K |
|
1046
Carpenter Technology
CRS
$30B
| $423K | ﹤0.01% |
7,538
+589
| +8% | +$28.8K |
|
1047
Plexus
PLXS
$6.81B
| $422K | ﹤0.01% |
4,294
+306
| +8% | +$28K |
|
1048
BlackLine
BL
$1.69B
| $421K | ﹤0.01% |
7,827
+830
| +12% | +$46.1K |
|
1049
Omega Healthcare
OHI
$15.4B
| $420K | ﹤0.01% |
13,695
-241
| -2% | -$6.96K |
|
1050
Healthcare Realty
HR
$7.42B
| $420K | ﹤0.01% |
22,246
-394
| -2% | -$7.61K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.